The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time.

A deeper knowledge about histopathological criteria with a significant impact on the prognosis of patients with glioblastomas is worthwhile, since these patients may show a considerable difference in the time of survival. Investigation of the morphology of perinecrotic tumor cell nuclei is a promising approach, because the expression of specific molecules in these cells has been associated with a more aggressive behaviour of the tumors. In our series of patients with documented clinical course, 11 patients had a survival of at least 24 months and we compared this group with a group of 10 patients with maximum survival of 12 months. Digital microscopic image analysis was performed in paraffin sections from the primary surgical specimen. Three hundred perinecrotic tumor cell nuclei per case and 300 nuclei per case from tumor cells lying more distant from the tumor necroses ('distant zone' nuclei) were measured. The ratio for the numerical nuclear density between both types of nuclei was significantly larger in cases with short survival indicating a more pronounced nuclear density of perinecrotic nuclei in relation to the 'distant zone' nuclei in these tumors. In cases with long survival, on the contrary, perinecrotic tumor cells exhibited an only slightly larger numerical density compared with 'distant zone' nuclei. Mean values and standard deviations from parameters of nuclear shape (Fourier-amplitudes) had significantly smaller values in short-time survivors indicating a tendency towards a more circular nuclear shape with less pronounced intratumoral variation in that group. Based on the morphometric results, all cases could be correctly reclassified as short- or long-time survivors by means of cross-validated discriminant analysis. In conclusion, the results confirm significant morphological differences between tumors from patients with short and with long survival regarding morphology of both types of tumor cell nuclei. It seems likely, that histomorphometry of tumor cell nuclei could be a promising approach for the assessment of the individual prognosis of patients with glioblastomas.

[1]  L. Bozzao,et al.  Radiological assessment of necrosis in glioblastoma: variability and prognostic value , 1998, Neuroradiology.

[2]  Andreas von Deimling,et al.  Impact of Genotype and Morphology on the Prognosis of Glioblastoma , 2002, Journal of neuropathology and experimental neurology.

[3]  G. Besson,et al.  [Glioblastomas: clinical study and search for prognostic factors]. , 2002, Neuro-Chirurgie.

[4]  Reinhold Nafe,et al.  Data Analysis for Comparative Histometry in Pathology - I. Classification Procedures and other Statistical Methods , 2000 .

[5]  P. Celli,et al.  Long-term survival in a patient with supratentorial glioblastoma: clinical considerations , 1998, The Italian Journal of Neurological Sciences.

[6]  Erwin G. Van Meir.  Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. , 1996, Neurosurgery.

[7]  W. Mackillop,et al.  A population-based study of glioblastoma multiforme. , 2001, International journal of radiation oncology, biology, physics.

[8]  K. Aldape,et al.  Aberrant p 53 , mdm 2 , and Proliferation Differ in Glioblastomas from Long-Term Compared with Typical Survivors 1 , 2002 .

[9]  R Nafe,et al.  EGFR gene amplification in glioblastomas. Is there a relationship with morphology of tumor cell nuclei and proliferative activity? , 2001, Analytical and quantitative cytology and histology.

[10]  Daniel J Brat,et al.  Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma , 2004, Laboratory Investigation.

[11]  Daniel J Brat,et al.  Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population , 2004, Cancer Research.

[12]  Reinhold Nafe,et al.  Morphology of Tumor Cell Nuclei Is Significantly Related with Survival Time of Patients with Glioblastomas , 2005, Clinical Cancer Research.

[13]  H. Hydén,et al.  A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .

[14]  M. West,et al.  Gene expression profiling and genetic markers in glioblastoma survival. , 2005, Cancer research.

[15]  S B Green,et al.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme , 1987, Cancer.

[16]  E. Cuny,et al.  Association of elevated glial expression of interleukin-1beta with improved survival in patients with glioblastomas multiforme. , 2002, Journal of neurosurgery.

[17]  W. Schlote,et al.  Regional heterogeneity of EGFR gene amplification and nuclear morphology in glioblastomas. An investigation using laser microdissection and pressure catapulting. , 2004, Analytical and quantitative cytology and histology.

[18]  K. Ligon,et al.  Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma , 2005, Journal of neuropathology and experimental neurology.

[19]  Douglas C. Miller,et al.  Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. , 2003, Human pathology.

[20]  J. Cairncross,et al.  Which glioblastoma multiforme patient will become a long‐term survivor? A population‐based study , 1999, Annals of neurology.

[21]  Takuya Watanabe,et al.  Molecular genetic analysis of deep-seated glioblastomas. , 2004, Cancer genetics and cytogenetics.